TDOC - Why Teladoc and Livongo Stocks Jumped Today
Shares of Teladoc Health (NYSE: TDOC) and Livongo Health (NASDAQ: LVGO) climbed on Monday, following positive analyst commentary. As of 1:50 p.m. EDT, both stocks were up more than 7%.
Credit Suisse analyst Jailendra Singh upgraded his rating on Teladoc's stock from neutral to outperform and boosted his price forecast from $225 to $249. Singh's new target price represents potential gains of roughly 25% for investors, based on Teladoc's current price near $200.
Credit Suisse analyst Jailendra Singh says a merger between Teladoc and Livongo will create a powerful force in digital health. Image source: Getty Images.